Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 10773 Tablets [Phase 1]

View source ↗

Summary

Phase 1 trial update reports on safety, tolerability, pharmacokinetics and pharmacodynamics of multiple rising doses of BI 10773 in adults with Type 2 diabetes,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BI 10773

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2014-07-04